NephroCheck Test, manufactured by San Diego-based Astute Medical, provides a score indicating the patient’s likelihood of developing acute kidney injury within the following 12 hours. There are currently no FDA-approved or cleared tests on the market assessing the risk of developing AKI.
More articles on the FDA:
Recent device recall is largest single-day event ever on FDA record
FDA fast tracks Pfizer’s C. diff vaccine
FDA releases API for medical device data
